Breast cancer research stalled by funding crisis for early-career scientists
A major research foundation has identified systemic barriers—shrinking grants, lack of trial leadership roles, and poor mentorship—that are forcing early-career breast cancer researchers out of the field. The findings underscore a critical pipeline problem: without strategic investment in these scientists now, the pace of treatment advances could slow significantly.
Originaltitel: Invest where impact begins: recommendations from Breast Cancer Research Foundation Early Career Investigator Working Group (Part 1 of 2)
Early-career investigators face growing challenges: dwindling public funding, limited trial leadership opportunities, systemic mentorship barriers, and widening global disparities. At the 20th Breast International Group (BIG) – NCI National Clinical Trials Network (NCTN) annual meeting, four key themes emerged: funding, mentorship, clinical trials, and translational research. This report outlines recommendations for funding and mentorship. Investment in this area is strategic to ensure continued advances for patients globally.